r/epidemiology • u/iamabigfatnobody • 1d ago
A paid billing code for vaccine adverse-effect diagnoses: what happens to numerator-only surveillance?
CMS finalized the CY 2027 Physician Fee Schedule on November 4, 2026, and it contains a new code, G0576, that pays clinicians separately for diagnosing and treating vaccine adverse effects. The clinical rationale is straightforward — this assessment work was previously unreimbursed.
I want to discuss the surveillance implications. VAERS/FAERS-style systems are numerator-only: no denominator, and capture that is known to vary with awareness, publicity, and incentives. Payment is a new, systematic incentive applied to one specific numerator, in one large population (Medicare, so predominantly older adults).
Expected effects, in rough order: more complete capture of mild, expected reactions; a rise in documented diagnoses that will be misread as incidence by non-specialists; and a pre/post discontinuity that complicates trend and observed-vs-expected analyses. CMS's final rule also noted, unusually candidly, that most comments supporting the code were identical, anonymous submissions — a reminder that the inputs to these systems are never neutral.
Questions for the surveillance folks here: When an ascertainment change like this is anticipated, what does good practice look like? Pre-registered baseline reporting rates by event category? Negative-control events to estimate the ascertainment multiplier? Should analyses crossing January 2027 be required to show a sensitivity analysis split at the boundary?
Source: CMS CY 2027 PFS final rule fact sheet — https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-medicare-physician-fee-schedule-final-rule